Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Russi, Elvio G ^a   Raber Durlacher, Judith E ^b   Sonis, Stephen T ^c  

^a A O S Croce e Carle   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; REACTIVE OXYGEN METABOLITE;

ARTICLE; CACHEXIA; CANCER FATIGUE; CANCER PATIENT; CHEMORADIOTHERAPY; COGNITIVE DEFECT; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; HEAD AND NECK CANCER; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; MUCOSA INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE INJURY; TREATMENT RESPONSE; HEAD AND NECK NEOPLASMS; METABOLISM; MUCOSA; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; HEAD AND NECK NEOPLASMS; HUMANS; INFLAMMATION; MUCOUS MEMBRANE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84897496832     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/518261     Document Type: Article

References (196)

1. Aprile G., Ramoni M., Keefe D., Sonis S., Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy. Cancer 2008 112 2 284 292 2-s2.0-38049007891 10.1002/cncr.23182
2. Xiao C., Hanlon A., Zhang Q., Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncology 2013 49 360 366
3. Andreassen C., Sonis S. T., Keefe D. M., The biological basis for differences in normal tissue response to radiation therapy and strategies to establish predictive assays for individual complication risk. Pathobiology of Cancer Regimen-Related Toxicities 2013 New York, NY, USA Springer 19 33
4. Pratesi N., Mangoni M., Mancini I., Paiar F., Simi L., Livi L., Cassani S., Buglione M., Grisanti S., Almici C., Polli C., Saieva C., Magrini S. M., Biti G., Pazzagli M., Orlando C., Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Radiotherapy and Oncology 2011 99 3 356 361 2-s2.0-79960366539 10.1016/j.radonc.2011.05.062
5. Werbrouck J., de Ruyck K., Duprez F., Veldeman L., Claes K., van Eijkeren M., Boterberg T., Willems P., Vral A., de Neve W., Thierens H., Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. International Journal of Radiation Oncology, Biology, Physics 2009 73 4 1187 1195 2-s2.0-61349169578 10.1016/j.ijrobp.2008.08.073
6. Numico G., Russi E. G., Vitiello R., Sorrentino R., Colantonio I., Cipolat M., Taglianti R. V., Pelissero A., Fea E., Granetto C., di Costanzo G., Gasco M., Garrone O., Occelli M., Merlano M., Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule. International Journal of Radiation Oncology, Biology, Physics 2006 66 3 731 737 2-s2.0-33748949062 10.1016/j.ijrobp.2006.05.059 (Pubitemid 44436711)
7. Merlano M., Russi E., Benasso M., Corvò R., Colantonio I., Vigna-Taglianti R., Vigo V., Bacigalupo A., Numico G., Crosetto N., Gasco M., Lo Nigro C., Vitiello R., Violante S., Garrone O., Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. Annals of Oncology 2011 22 3 712 717 2-s2.0-79952012758 10.1093/annonc/mdq412
8. Forastiere A. A., Goepfert H., Maor M., Pajak T. F., Weber R., Morrison W., Glisson B., Trotti A., Ridge J. A., Chao C., Peters G., Lee D.-J., Leaf A., Ensley J., Cooper J., Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. The New England Journal of Medicine 2003 349 22 2091 2098 2-s2.0-0345714860 10.1056/NEJMoa031317 (Pubitemid 37464533)
9. Trotti A., Bellm L. A., Epstein J. B., Frame D., Fuchs H. J., Gwede C. K., Komaroff E., Nalysnyk L., Zilberberg M. D., Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiotherapy and Oncology 2003 66 3 253 262 2-s2.0-0038399940 10.1016/S0167-8140(02)00404-8 (Pubitemid 36556043)
10. Sonis S. T., The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Critical Reviews in Oral Biology and Medicine 2002 13 5 380 389 2-s2.0-0036044091 (Pubitemid 36569342)
11. Sonis S., Haddad R., Posner M., Watkins B., Fey E., Morgan T. V., Mookanamparambil L., Ramoni M., Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral Oncology 2007 43 3 289 300 2-s2.0-33846862650 10.1016/j.oraloncology.2006. 03.014 (Pubitemid 46228015)
12. Janko M., Ontiveros F., Fitzgerald T. J., Deng A., DeCicco M., Rock K. L., IL-1 generated subsequent to radiation-induced tissue injury contributes to the pathogenesis of radiodermatitis. Radiation Research 2012 178 166 172
13. Chen Y., Rubin P., Williams J., Hernady E., Smudzin T., Okunieff P., Circulating IL-6 as a predictor of radiation pneumonitis. International Journal of Radiation Oncology, Biology, Physics 2001 49 3 641 648 2-s2.0-0035283721 10.1016/S0360-3016(00)01445-0 (Pubitemid 32112192)
14. Hildebrandt M. A. T., Komaki R., Liao Z., Gu J., Chang J. Y., Ye Y., Lu C., Stewart D. J., Minna J. D., Roth J. A., Lippman S. M., Cox J. D., Hong W. K., Spitz M. R., Wu X., Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS ONE 2010 5 8 2-s2.0-77957867311 10.1371/journal.pone. 0012402 e12402
15. Sonis S. T., New thoughts on the initiation of mucositis. Oral Diseases 2010 16 7 597 600 2-s2.0-77956853059 10.1111/j.1601-0825.2010.01681.x
16. Siva S., Macmanus M. P., Martin R. F., Martin O. A., Abscopal effects of radiation therapy: a clinical review for the radiobiologist. Cancer Letters 2013 10.1016/j.canlet.2013.09.018
17. Cerra F. B., The systemic septic response: multiple systems organ failure. Critical Care Clinics 1985 1 3 591 607 2-s2.0-0022209453 (Pubitemid 16087136)
18. Bone R. C., The pathogenesis of sepsis. Annals of Internal Medicine 1991 115 6 457 469 2-s2.0-0026048714
19. Argiris A., Brockstein B. E., Haraf D. J., Stenson K. M., Mittal B. B., Kies M. S., Rosen F. R., Jovanovic B., Vokes E. E., Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clinical Cancer Research 2004 10 6 1956 1962 2-s2.0-1642382955 10.1158/1078-0432.CCR-03-1077 (Pubitemid 38375553)
20. Mell L. K., Dignam J. J., Salama J. K., Cohen E. E. W., Polite B. N., Dandekar V., Bhate A. D., Witt M. E., Haraf D. J., Mittal B. B., Vokes E. E., Weichselbaum R. R., Predictors of competing mortality in advanced head and neck cancer. Journal of Clinical Oncology 2010 28 1 15 20 2-s2.0-73949129781 10.1200/JCO.2008.20.9288
21. Angus D. C., van der Poll T., Severe sepsis and septic shock. The New England Journal of Medicine 2013 369 840 851
22. Forner L., Larsen T., Kilian M., Holmstrup P., Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. Journal of Clinical Periodontology 2006 33 6 401 407 2-s2.0-33646685234 10.1111/j.1600-051X.2006.00924.x (Pubitemid 43742620)
23. Raber-Durlacher J. E., Laheij A. M. G. A., Epstein J. B., Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study. Support Care Cancer 2013 21 1621 1627
24. Lever A., Mackenzie I., Sepsis: definition, epidemiology, and diagnosis. British Medical Journal 2007 335 7625 879 883 2-s2.0-35948948662 10.1136/bmj.39346.495880.AE (Pubitemid 350069465)
25. Castellani P., Balza E., Rubartelli A., Inflammation, DAMPs, tumor development, and progression: a vicious circle orchestrated by redox signaling. Antioxidants & Redox Signaling 2013 20 7 1086 1097 10.1089/ars.2012.5164
26. Lockhart P. B., Sonis S. T., Alterations in the oral mucosa caused by chemotherapeutic agents. A histologic study. Journal of Dermatologic Surgery and Oncology 1981 7 12 1019 1025 2-s2.0-0019776795 (Pubitemid 12197971)
27. Bowen J. M., Keefe D. M. K., New pathways for alimentary mucositis. Journal of Oncology 2008 2008 7 10.1155/2008/907892 907892
28. Sonis S. T., The pathobiology of mucositis. Nature Reviews Cancer 2004 4 4 277 284 2-s2.0-1942469964 (Pubitemid 38525283)
29. Laheij A. M. G. A., de Soet J. J., von dem Borne P. A., Kuijper E. J., Kraneveld E. A., van Loveren C., Raber-Durlacher J. E., Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients. Supportive Care in Cancer 2012 20 3231 3240 2-s2.0-84859928862 10.1007/s00520-012-1463-2
30. Barasch A., Elad S., Altman A., Damato K., Epstein J., Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Supportive Care in Cancer 2006 14 6 528 532 2-s2.0-33746070848 10.1007/s00520-006-0066-1
31. Corvò R., Amichetti M., Ascarelli A., Arcangeli G., Buffoli A., Cellini N., Cionini L., de Renzis C., Emiliani E., Franchini P., Gabriele P., Gobitti C., Ruggieri F. G., Bertoni F., Magrini S. M., Marmiroli L., Orsatti M., Panizza G. M., Tordiglione M., Ziccarelli L., Gava A., Zorat P. L., Ghelfi R., Serra G. F., Vitale V., Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. European Journal of Cancer Care 2008 17 3 270 277 2-s2.0-42449092062 10.1111/j.1365-2354.2007. 00855.x
32. Donnelly J. P., Bellm L. A., Epstein J. B., Sonis S. T., Symonds R. P., Antimicrobial therapy to prevent or treat oral mucositis. The Lancet Infectious Diseases 2003 3 7 405 412 2-s2.0-0038788959 10.1016/S1473-3099(03)00668-6 (Pubitemid 36791117)
33. El-Sayed S., Nabid A., Shelley W., Hay J., Balogh J., Gelinas M., MacKenzie R., Read N., Berthelet E., Lau H., Epstein J., Delvecchio P., Ganguly P. K., Wong F., Burns P., Tu D., Pater J., Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. Journal of Clinical Oncology 2002 20 19 3956 3963 2-s2.0-0036789706 10.1200/JCO.2002.05.046
34. Napeñas J. J., Brennan M. T., Coleman S., Kent M. L., Noll J., Frenette G., Nussbaum M. L., Mougeot J.-L., Paster B. J., Lockhart P. B., Bahrani-Mougeot F. K., Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2010 109 4 554 560 2-s2.0-77949449526 10.1016/j.tripleo.2009.11.015
35. Soga Y., Maeda Y., Ishimaru F., Tanimoto M., Maeda H., Nishimura F., Takashiba S., Bacterial substitution of coagulase-negative staphylococci for streptococci on the oral mucosa after hematopoietic cell transplantation. Supportive Care in Cancer 2011 19 7 995 1000 2-s2.0-80051598048 10.1007/s00520-010-0923-9
36. van der Velden W. J. F. M., Donnelly J. P., Blijlevens N. M. A., Lymphocyte subsets, granulocytecolony-stimulating factor responsiveness and post-stem cell transplantation infections: mucositis is the underestimated confounder? Cytotherapy 2012 14 3 381 383 2-s2.0-84856894613 10.3109/14653249.2011.650162
37. Denham J. W., Hauer-Jensen M., The radiotherapeutic injury-a complex "wound'. Radiotherapy and Oncology 2002 63 2 129 145 2-s2.0-0036283219 10.1016/S0167-8140(02)00060-9 (Pubitemid 34628401)
38. Odyuo M. M., Sharan R. N., Differential DNA strand breaking ablities of OH and ROS generating radiomimetic chemicals and γ -rays: study of plasmid DNA, pMTa4, in vitro. Free Radical Research 2005 39 5 499 505 2-s2.0-19044386807 10.1080/10715760500072305 (Pubitemid 40711882)
39. Azzam E., Toledo S., Harris A., Ivanov V., Zhou H., Amundson S., Sonis S. T., Keefe D. M., The ionizing radiation-induced bystander effect: evidence, mechanism, and significance. Pathobiology of Cancer Regimen-Related Toxicities 2013 New York, NY, USA Springer 35 61
40. Krysko D. V., Agostinis P., Krysko O., Garg A. D., Bachert C., Lambrecht B. N., Vandenabeele P., Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends in Immunology 2011 32 4 157 164 2-s2.0-79953068336 10.1016/j.it.2011.01.005
41. Leach J. K., van Tuyle G., Lin P.-S., Schmidt-Ullrich R., Mikkelsen R. B., Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Research 2001 61 10 3894 3901 2-s2.0-0035872421 (Pubitemid 32720947)
42. Arterbery V. E., Pryor W. A., Jiang L., Sehnert S. S., Foster W. M., Abrams R. A., Williams J. R., Wharam M. D. Jr., Risby T. H., Breath ethane generation during clinical total body irradiation as a marker of oxygen-free-radical-mediated lipid peroxidation: a case study. Free Radical Biology and Medicine 1994 17 6 569 576 2-s2.0-0027987026 10.1016/0891-5849(94) 90096-5 (Pubitemid 24367939)
43. Hayashi T., Kusunoki Y., Hakoda M., Morishita Y., Kubo Y., Maki M., Kasagi F., Kodama K., MacPhee D. G., Kyoizumi S., Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. International Journal of Radiation Biology 2003 79 2 129 136 2-s2.0-0037317216 (Pubitemid 36183071)
44. Lotze M. T., Zeh H. J., Rubartelli A., Sparvero L. J., Amoscato A. A., Washburn N. R., DeVera M. E., Liang X., Tör M., Billiar T., The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunological Reviews 2007 220 1 60 81 2-s2.0-35748945719 10.1111/j.1600-065X.2007.00579.x (Pubitemid 350045579)
45. Neriishi K., Nakashima E., Delongchamps R. R., Persistent subclinical inflammation among A-bomb survivors. International Journal of Radiation Biology 2001 77 4 475 482 2-s2.0-0035075485 10.1080/09553000010024911 (Pubitemid 32281128)
46. Sonis S. T., Pathobiology of oral mucositis: novel insights and opportunities. Journal of Supportive Oncology 2007 5 9 3 11 2-s2.0-35649021206 (Pubitemid 350031828)
47. Ueda T., Toyoshima Y., Moritani T., Ri K., Otsuki N., Kushihashi T., Yasuhara H., Hishida T., Protective effect of dipyridamole against lethality and lipid peroxidation in liver and spleen of the ddY mouse after whole-body irradiation. International Journal of Radiation Biology 1996 69 2 199 204 2-s2.0-0030012032 10.1080/095530096146039 (Pubitemid 26132792)
48. Braun S., Hanselmann C., Gassmann M. G., auf dem Keller U., Born-Berclaz C., Chan K., Kan Y. W., Werner S., Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Molecular and Cellular Biology 2002 22 15 5492 5505 2-s2.0-0036318224 10.1128/MCB.22.15.5492-5505.2002 (Pubitemid 34755759)
49. McDonald J. T., Kim K., Norris A. J., Vlashi E., Phillips T. M., Lagadec C., della Donna L., Ratikan J., Szelag H., Hlatky L., McBride W. H., Ionizing radiation activates the Nrf2 antioxidant response. Cancer Research 2010 70 21 8886 8895 2-s2.0-78449270816 10.1158/0008-5472.CAN-10-0171
50. Srikrishna G., Freeze H. H., Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009 11 7 615 628 2-s2.0-67650482883 10.1593/neo.09284
51. Seong S.-Y., Matzinger P., Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nature Reviews Immunology 2004 4 6 469 478 2-s2.0-2942627626 (Pubitemid 38745558)
52. Bianchi M. E., DAMPs, PAMPs and alarmins: all we need to know about danger. Journal of Leukocyte Biology 2007 81 1 1 5 2-s2.0-33845951211 10.1189/jlb.0306164 (Pubitemid 46028489)
53. Sonis S. T., Oral mucositis. Anti-Cancer Drugs 2011 22 7 607 612 2-s2.0-79960467034 10.1097/CAD.0b013e3283462086
54. Sims G. P., Rowe D. C., Rietdijk S. T., Herbst R., Coyle A. J., HMGB1 and RAGE in inflammation and cancer. Annual Review of Immunology 2010 28 367 388 2-s2.0-77952298772 10.1146/annurev.immunol.021908.132603
55. Hreggvidsdottir H. S., Östberg T., Wähämaa H., Schierbeck H., Aveberger A.-C., Klevenvall L., Palmblad K., Ottosson L., Andersson U., Harris H. E., The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. Journal of Leukocyte Biology 2009 86 3 655 662 2-s2.0-70149098507 10.1189/jlb.0908548
56. Andersson U., Tracey K. J., HMGB1 is a therapeutic target for sterile inflammation and infection. Annual Review of Immunology 2011 29 139 162 2-s2.0-79953066407 10.1146/annurev-immunol-030409-101323
57. El-Saghire H., Michaux A., Thierens H., Baatout S., Low doses of ionizing radiation induce immune-stimulatory responses in isolated human primary monocytes. International Journal of Molecular Medicine 2013 32 1407 1414
58. Wolfson R. K., Chiang E. T., Garcia J. G. N., HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvascular Research 2011 81 2 189 197 2-s2.0-79651474104 10.1016/j.mvr.2010. 11.010
59. Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K. J., Cutting edge: HMG-1 as a mediator of acute lung inflammation. Journal of Immunology 2000 165 6 2950 2954 2-s2.0-0034664791
60. Sappington P. L., Yang R., Yang H., Tracey K. J., Delude R. L., Fink M. P., HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002 123 3 790 802 2-s2.0-0036724929 10.1053/gast.2002.35391 (Pubitemid 34977085)
61. Cavaillon J.-M., 'Septic plasma": an immunosuppressive milieu. American Journal of Respiratory and Critical Care Medicine 2002 166 11 1417 1418 2-s2.0-0036893263 10.1164/rccm.2209003 (Pubitemid 35387286)
62. de Vos F. Y. F. L., Willemse P. H. B., de Vries E. G. E., Gietema J. A., Endothelial cell effects of cytotoxics: balance between desired and unwanted effects. Cancer Treatment Reviews 2004 30 6 495 513 2-s2.0-4344609095 10.1016/j.ctrv.2004.05.003 (Pubitemid 39157851)
63. Blirando K., Hneino M., Martelly I., Benderitter M., Milliat F., François A., Mast cells and ionizing radiation induce a synergistic expression of inflammatory genes in endothelial cells by a mechanism involving p38 α MAP kinase and (p65) NF- B activation. Radiation Research 2012 178 556 567 10.1667/RR3058.1
64. Bae J.-S., Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Archives of Pharmacal Research 2012 35 1511 1523
65. Li M., Carpio D. F., Zheng Y., Bruzzo P., Singh V., Ouaaz F., Medzhitov R. M., Beg A. A., An essential role of the NF- B/toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. Journal of Immunology 2001 166 12 7128 7135 2-s2.0-0035877013 (Pubitemid 32525583)
66. Kaplan A. P., Joseph K., Shibayama Y., Reddigari S., Ghebrehiwet B., Silverberg M., The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. Advances in Immunology 1997 66 225 272 2-s2.0-0030885721 (Pubitemid 27430944)
67. Rock K. L., Kono H., The inflammatory response to cell death. Annual Review of Pathology 2008 3 99 126 2-s2.0-41749104586 10.1146/annurev. pathmechdis.3.121806.151456 (Pubitemid 351488277)
68. Murphy C. K., Fey E. G., Watkins B. A., Wong V., Rothstein D., Sonis S. T., Efficacy of superoxide dismutase mimetic M40403 in attenuating radiation-induced oral mucositis in hamsters. Clinical Cancer Research 2008 14 13 4292 4297 2-s2.0-48249114805 10.1158/1078-0432.CCR-07-4669
69. Riley P. A., Free radicals in biology: oxidative stress and the effects of ionizing radiation. International Journal of Radiation Biology 1994 65 1 27 33 2-s2.0-0027954494 (Pubitemid 24063526)
70. Zhao W., Diz D. I., Robbins M. E., Oxidative damage pathways in relation to normal tissue injury. British Journal of Radiology 2007 80 1 S23 S31 2-s2.0-34948897918 10.1259/bjr/18237646 (Pubitemid 47517796)
71. Castellheim A., Brekke O.-L., Espevik T., Harboe M., Mollnes T. E., Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scandinavian Journal of Immunology 2009 69 6 479 491 2-s2.0-65349105896 10.1111/j.1365-3083.2009.02255.x
72. Kono H., Rock K. L., How dying cells alert the immune system to danger. Nature Reviews Immunology 2008 8 4 279 289 2-s2.0-41149118513 10.1038/nri2215 (Pubitemid 351432799)
73. Wadachi R., Hargreaves K. M., Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection. Journal of Dental Research 2006 85 1 49 53 2-s2.0-33644986066 10.1177/154405910608500108 (Pubitemid 43827762)
74. Liu T., Gao Y.-J., Ji R.-R., Emerging role of Toll-like receptors in the control of pain and itch. Neuroscience Bulletin 2012 28 131 144 2-s2.0-84857461539 10.1007/s12264-012-1219-5
75. Allan E., Skin. The Radiotherapy of Malignant Disease 1991 New York, NY, USA Springer 133 144 10.1007/978-1-4471-3168-7-6
76. Moss W. T., Gold S., The acute effects of radiations on the physiology of small blood vessels. The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine 1963 90 294 299 2-s2.0-78651160959
77. Schramm L. P., Weaver L. C., Polosa C., Spinal sympathetic interneurons: their identification and roles after spinal cord injury. Progress in Brain Research 2006 152 Elsevier 27 37 10.1016/S0079-6123(05)52002-8
78. Straub R. H., Mayer M., Kreutz M., Leeb S., Scholmerich J., Falk W., Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. Journal of Leukocyte Biology 2000 67 4 553 558 2-s2.0-0033850002
79. Fajardo L. F., The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncologica 2005 44 1 13 22 2-s2.0-13844267558 10.1080/02841860510007440 (Pubitemid 40249124)
80. Goldin-Lang P., Pels K., Tran Q.-V., Szotowski B., Wittchen F., Antoniak S., Willich T., Witt H., Hummel M., Lenze D., Poller W., Schultheiss H.-P., Rauch U., Effect of ionizing radiation on cellular procoagulability and co-ordinated gene alterations. Haematologica 2007 92 8 1091 1098 2-s2.0-35748932958 10.3324/haematol.10702 (Pubitemid 350144216)
81. Al-Dasooqi N., Gibson R. J., Bowen J. M., Keefe D. M., Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis? Cancer Chemotherapy and Pharmacology 2009 64 1 1 9 2-s2.0-63649143909 10.1007/s00280-009-0984-y
82. Parks W. C., Wilson C. L., López-Boado Y. S., Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Reviews Immunology 2004 4 8 617 629 2-s2.0-3543134126 (Pubitemid 39025047)
83. Paris F., Fuks Z., Kang A., Capodieci P., Juan G., Ehleiter D., Haimovitz-Friedman A., Cordon-Cardo C., Kolesnick R., Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001 293 5528 293 297 2-s2.0-0035854479 10.1126/science.1060191 (Pubitemid 32694744)
84. Li C.-Y., Hong Y., Tao X.-A., Xia J., Cheng B., The correlation between the severity of radiotherapy-induced glossitis and endothelial cell injury in local tissues in a rat model. Medicina Oral, Patologia Oral y Cirugia Bucal 2011 16 6 e711 e715 2-s2.0-80052558523 10.4317/medoral.17057
85. Wearing H. J., Sherratt J. A., Keratinocyte growth factor signalling: a mathematical model of dermal-epidermal interaction in epidermal wound healing. Mathematical Biosciences 2000 165 1 41 62 2-s2.0-0034075994 10.1016/S0025- 5564(00)00008-0 (Pubitemid 30305421)
86. Logan R. M., Stringer A. M., Bowen J. M., Gibson R. J., Sonis S. T., Keefe D. M. K., Serum levels of NF B and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biology and Therapy 2008 7 7 1139 1145 2-s2.0-47949090409
87. Sonis S. T., Bast R. J., Kufe D., Pollock R., Oral complications of cancer therapy. Holland-Frei Cancer Medicine 2000 Hamilton, Canada BC Decker 2371 2379
88. Besedovsky H. O., del Rey A., Immune-neuro-endocrine interactions: facts and hypotheses. Endocrine Reviews 1996 17 1 64 102 2-s2.0-0030043899 10.1210/er.17.1.64 (Pubitemid 26061368)
89. Ciofi P., Garret M., Lapirot O., Lafon P., Loyens A., Prévot V., Levine J. E., Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus. Endocrinology 2009 150 12 5509 5519 2-s2.0-71949104669 10.1210/en.2009-0584
90. Schubert C., Hong S., Natarajan L., Mills P. J., Dimsdale J. E., The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain, Behavior, and Immunity 2007 21 4 413 427 2-s2.0-34047158255 10.1016/j.bbi.2006.11.004 (Pubitemid 46528677)
91. Guttridge D. C., Mayo M. W., Madrid L. V., Wang C.-Y., Baldwin A. S. Jr., NF- B-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000 289 5488 2363 2365 2-s2.0-0034730251 10.1126/science.289. 5488.2363
92. Couch M., Lai V., Cannon T., Guttridge D., Zanation A., George J., Hayes D. N., Zeisel S., Shores C., Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment. Head & Neck 2007 29 4 401 411 2-s2.0-34247250705 10.1002/hed.20447 (Pubitemid 46623505)
93. George J., Cannon T., Lai V., Richey L., Zanation A., Hayes D. N., Shores C., Guttridge D., Couch M., Cancer cachexia syndrome in head and neck cancer patients: part II. Pathophysiology. Head & Neck 2007 29 5 497 507 2-s2.0-34248357378 10.1002/hed.20630 (Pubitemid 46732590)
94. Grossberg A. J., Scarlett J. M., Marks D. L., Hypothalamic mechanisms in cachexia. Physiology and Behavior 2010 100 5 478 489 2-s2.0-77953810296 10.1016/j.physbeh.2010.03.011
95. Bodey G. P., Rodriguez V., Chang H. Y., Narboni G., Fever and infection in leukemic patients. A study of 494 consecutive patients. Cancer 1978 41 4 1610 1622 2-s2.0-0017841794 (Pubitemid 8333322)
96. Sonis S. T., Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology 2009 45 12 1015 1020 2-s2.0-70449525211 10.1016/j.oraloncology.2009.08.006
97. Evans W. J., Morley J. E., Argilés J., Bales C., Baracos V., Guttridge D., Jatoi A., Kalantar-Zadeh K., Lochs H., Mantovani G., Marks D., Mitch W. E., Muscaritoli M., Najand A., Ponikowski P., Fanelli F. R., Schambelan M., Schols A., Schuster M., Thomas D., Wolfe R., Anker S. D., Cachexia: a new definition. Clinical Nutrition 2008 27 6 793 799 2-s2.0-55749085001 10.1016/j.clnu.2008.06.013
98. Fearon K., Strasser F., Anker S. D., Bosaeus I., Bruera E., Fainsinger R. L., Jatoi A., Loprinzi C., MacDonald N., Mantovani G., Davis M., Muscaritoli M., Ottery F., Radbruch L., Ravasco P., Walsh D., Wilcock A., Kaasa S., Baracos V. E., Definition and classification of cancer cachexia: an international consensus. The Lancet Oncology 2011 12 5 489 495 2-s2.0-79955399340 10.1016/S1470-2045(10)70218-7
99. Pradeu T., Cooper E. L., The danger theory: 20 years later. Frontiers in Immunology 2012 3, article 287 10.3389/fimmu.2012.00287
100. Palm N. W., Medzhitov R., Pattern recognition receptors and control of adaptive immunity. Immunological Reviews 2009 227 1 221 233 2-s2.0-58049220365 10.1111/j.1600-065X.2008.00731.x
101. Jong S. P., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J.-Y., Strassheim D., Sohn J.-W., Yamada S., Maruyama I., Banerjee A., Ishizaka A., Abraham E., High mobility group box 1 protein interacts with multiple Toll-like receptors. American Journal of Physiology 2006 290 3 C917 C924 2-s2.0-33645461206 10.1152/ajpcell.00401.2005
102. Schmidt A. M., Hori O., Cao R., Yan S. D., Brett J., Wautier J.-L., Ogawa S., Kuwabara K., Matsumoto M., Stern D., A novel cellular receptor for advanced glycation end products. Diabetes 1996 45 3 S77 S80 2-s2.0-0029882671
103. Criswell T., Leskov K., Miyamoto S., Luo G., Boothman D. A., Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene 2003 22 37 5813 5827 2-s2.0-0141645610 10.1038/sj.onc.1206680 (Pubitemid 37176702)
104. van Beijnum J. R., Buurman W. A., Griffioen A. W., Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 2008 11 1 91 99 2-s2.0-41049117932 10.1007/s10456-008-9093-5
105. Logan R. M., Gibson R. J., Sonis S. T., Keefe D. M. K., Nuclear factor- B (NF- B) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncology 2007 43 4 395 401 2-s2.0-33947198190 10.1016/j.oraloncology.2006.04.011 (Pubitemid 46420789)
106. Sonis S. T., O'Donnell K. E., Popat R., Bragdon C., Phelan S., Cocks D., Epstein J. B., The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis. Oral Oncology 2004 40 2 170 176 2-s2.0-0348049989 10.1016/S1368-8375(03)00148-9 (Pubitemid 38030361)
107. Morvan F. O., Baroukh B., Ledoux D., Caruelle J.-P., Barritaul D., Godeau G., Saffar J.-L., An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters. American Journal of Pathology 2004 164 2 739 746 2-s2.0-1542289715 (Pubitemid 38364687)
108. Al-Dasooqi N., Gibson R. J., Bowen J. M., Logan R. M., Stringer A. M., Keefe D. M., Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat. Experimental Biology and Medicine 2010 235 10 1244 1256 2-s2.0-77957832701 10.1258/ebm.2010.010082
109. Basbaum A. I., Bautista D. M., Scherrer G., Julius D., Cellular and molecular mechanisms of pain. Cell 2009 139 2 267 284 2-s2.0-70349845440 10.1016/j.cell.2009.09.028
110. Castellani M. L., Ciampoli C., Felaco M., Tetè S., Conti C. M., Salini V., de Amicis D., Orso C., Antinolfi P. L., Caraffa A., Cerulli G., Boscolo P., Theoharides T. C., Conti P., Kempuraj D., Neuropeptide substance P induces mRNA expression and secretion of CXCL8 chemokine, and HDC in human umbilical cord blood mast cells. Clinical and Investigative Medicine 2008 31 6 E362 E372 2-s2.0-57049124383
111. Guadagnolo A. B., Ang K. K., Ballo M. T., The skin. Radiation Oncology: Rationale, Technique, Results 2009 Mosby 141 157
112. Logan R. M., Stringer A. M., Bowen J. M., Yeoh A. S.-J., Gibson R. J., Sonis S. T., Keefe D. M. K., The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treatment Reviews 2007 33 5 448 460 2-s2.0-34548230499 10.1016/j.ctrv.2007.03.001 (Pubitemid 47324227)
113. Logan R. M., Gibson R. J., Bowen J. M., Stringer A. M., Sonis S. T., Keefe D. M. K., Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemotherapy and Pharmacology 2008 62 1 33 41 2-s2.0-42149113491 10.1007/s00280-007-0570-0 (Pubitemid 351537842)
114. Andrieu-Abadie N., Levade T., Sphingomyelin hydrolysis during apoptosis. Biochimica et Biophysica Acta 2002 1585 2-3 126 134 2-s2.0-0037203354 10.1016/S1388-1981(02)00332-3 (Pubitemid 36092076)
115. Dimanche-Boitrel M.-T., Rebillard A., Gulbins E., Petrache I., Sphingolipids and response to chemotherapy. Sphingolipids in Disease 2013 216 Springer 73 91 Handbook of Experimental Pharmacology 10.1007/978-3-7091-1511-4-4
116. Kolesnick R., Fuks Z., Radiation and ceramide-induced apoptosis. Oncogene 2003 22 37 5897 5906 2-s2.0-0141757451 10.1038/sj.onc.1206702 (Pubitemid 37176710)
117. Davis R. J., Letts D. L. G., Morgan D. D. W., Signal transduction by the JNK group of MAP kinases. Inflammatory Processes 2000 Basel, Switzerland Birkhäuser 13 21
118. Sonis S. T., Elting L. S., Keefe D., Peterson D. E., Schubert M., Hauer-Jensen M., Bekele B. N., Raber-Durlacher J., Donnelly J. P., Rubenstein E. B., Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004 100 9 1995 2025 2-s2.0-11144356545 (Pubitemid 38528741)
119. de Koning B. A. E., van Dieren J. M., Lindenbergh-Kortleve D. J., van der Sluis M., Matsumoto T., Yamaguchi K., Einerhand A. W., Samsom J. N., Pieters R., Nieuwenhuis E. E. S., Contributions of mucosal immune cells to methotrexate-induced mucositis. International Immunology 2006 18 6 941 949 2-s2.0-33745586794 10.1093/intimm/dxl030 (Pubitemid 43983289)
120. Gibson R. J., Keefe D. M. K., Thompson F. M., Clarke J. M., Goland G. J., Cummins A. G., Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Digestive Diseases and Sciences 2002 47 12 2751 2757 2-s2.0-0036907234 10.1023/A:1021061306913 (Pubitemid 35471617)
121. Sonis S. T., Peterson R. L., Edwards L. J., Lucey C. A., Wang L., Mason L., Login G., Ymamkawa M., Moses G., Bouchard P., Hayes L. L., Bedrosian C., Dorner A. J., Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncology 2000 36 4 373 381 2-s2.0-0033918355 10.1016/S1368-8375(00)00012-9 (Pubitemid 30427259)
122. Zhao J., Huang L., Belmar N., Buelow R., Fong T., Oral RDP58 allows CPT-11 dose intensification for enhanced tumor response by decreasing gastrointestinal toxicity. Clinical Cancer Research 2004 10 8 2851 2859 2-s2.0-1942438132 10.1158/1078-0432.CCR-03-0496 (Pubitemid 38509165)
123. Antin J. H., Lee S. J., Neuberg D., Alyea E., Soiffer R. J., Sonis S., Ferrara J. L. M., A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. Bone Marrow Transplantation 2002 29 5 373 377 2-s2.0-0036207335 10.1038/sj/bmt/1703394 (Pubitemid 34262638)
124. Logan R. M., Stringer A. M., Bowen J. M., Gibson R. J., Sonis S. T., Keefe D. M. K., Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemotherapy and Pharmacology 2009 63 2 239 251 2-s2.0-57149143703 10.1007/s00280-008-0732-8
125. Ong Z. Y., Gibson R. J., Bowen J. M., Stringer A. M., Darby J. M., Logan R. M., Yeoh A. S. J., Keefe D. M., Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis. Radiation Oncology 2010 5 1, article 22 2-s2.0-77952504110 10.1186/1748-717X-5-22
126. Sonis S. T., Scherer J., Phelan S., Lucey C. A., Barron J. E., O'Donnell K. E., Brennan R. J., Pan H., Busse P., Haley J. D., The gene expression sequence of radiated mucosa in in an animal mucositis model. Cell Proliferation 2002 35 supplement 1 93 102 2-s2.0-0036367518 (Pubitemid 34985152)
127. Ferrà C., de Sanjosé S., Lastra C. F., Martí F., Mariño E. L., Sureda A., Brunet S., Gallardo D., Berlanga J. J., García J., Grañena A., Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Bone Marrow Transplantation 1997 20 12 1075 1080 2-s2.0-17544394503 (Pubitemid 28043420)
128. Le Q.-T., Kim H. E., Schneider C. J., Muraközy G., Skladowski K., Reinisch S., Chen Y., Hickey M., Mo M., Chen M.-G., Berger D., Lizambri R., Henke M., Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. Journal of Clinical Oncology 2011 29 20 2808 2814 2-s2.0-79960257854 10.1200/JCO.2010.32.4095
129. Sonis S. T., Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis. Core Evidence 2009 4 199 205 2-s2.0-79959365828
130. Beaven A. W., Shea T. C., Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant. Drugs of Today 2007 43 7 461 473 2-s2.0-34548303424 10.1358/dot.2007.43.7.1119723 (Pubitemid 47344923)
131. Herbers A. H. E., van der Velden W. J. F. M., de Haan A. F. J., Donnelly J. P., Blijlevens N. M. A., Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM. Bone Marrow Transplant 2014 49 8 10 10.1038/bmt.2013.118
132. Sonis S. T., Schwartzberg L. S., Weidner S. M., Alterovitz G., From Bayesian modeling to genomic mapping: biologic validity of predictive single nucleotide polymorphism networks for chemotherapy-related side effects. Journal of Clinical Oncology 2013 31, abstract 9535
133. van der Meeren A., Vandamme M., Squiban C., Gaugler M.-H., Mouthon M.-A., Inflammatory reaction and changes in expression of coagulation proteins on lung endothelial cells after total-body irradiation in mice. Radiation Research 2003 160 6 637 646 2-s2.0-0348014924 10.1667/RR3087 (Pubitemid 37521706)
134. Panés J., Anderson D. C., Miyasaka M., Granger D. N., Role of leukocyte-endothelial cell adhesion in radiation-induced microvascular dysfunction in rats. Gastroenterology 1995 108 6 1761 1769 2-s2.0-0029015681 10.1016/0016-5085(95)90138-8
135. Wu J., Stevenson M. J., Brown J. M., Grunz E. A., Strawn T. L., Fay W. P., C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 4 698 704 2-s2.0-42249092845 10.1161/ATVBAHA.107. 160903 (Pubitemid 351651347)
136. Napoleone E., di Santo A., Peri G., Mantovani A., de Gaetano G., Donati M. B., Lorenzet R., The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. Journal of Leukocyte Biology 2004 76 1 203 209 2-s2.0-3042824612 10.1189/jlb.1003528 (Pubitemid 38857188)
137. Chu A. J., Tissue factor, blood coagulation, and beyond: an overview. International Journal of Inflammation 2011 2011 30 367284 10.4061/2011/367284
138. Conway E. M., Thrombomodulin and its role in inflammation. Seminars in Immunopathology 2012 34 1 107 125 2-s2.0-84857860942 10.1007/s00281-011-0282-8
139. Delvaeye M., Conway E. M., Coagulation and innate immune responses: can we view them separately? Blood 2009 114 12 2367 2374 2-s2.0-70350512348 10.1182/blood-2009-05-199208
140. Wang J., Zheng H., Ou X., Albertson C. M., Fink L. M., Herbert J.-M., Hauer-Jensen M., Hirudin ameliorates intestinal radiation toxicity in the rat: support for thrombin inhibition as strategy to minimize side-effects after radiation therapy and as countermeasure against radiation exposure. Journal of Thrombosis and Haemostasis 2004 2 11 2027 2035 2-s2.0-13244299030 10.1111/j.1538-7836.2004.00960.x (Pubitemid 40192757)
141. Al-Dasooqi N., Bowen J. M., Gibson R. J., Logan R. M., Stringer A. M., Keefe D. M., Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the dark agouti rat. International Journal of Experimental Pathology 2011 92 5 357 365 2-s2.0-80052842330 10.1111/j.1365-2613.2011.00771.x
142. Barcellos-Hoff M. H., How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiation Research 1998 150 5 S109 S120 2-s2.0-0031773119 (Pubitemid 28519056)
143. Yarnold J., Brotons M.-C. V., Pathogenetic mechanisms in radiation fibrosis. Radiotherapy and Oncology 2010 97 1 149 161 2-s2.0-77957884094 10.1016/j.radonc.2010.09.002
144. van Wart H. E., Birkedal-Hansen H., The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proceedings of the National Academy of Sciences of the United States of America 1990 87 14 5578 5582 2-s2.0-0025025442 10.1073/pnas.87.14.5578 (Pubitemid 20260224)
145. Mole R. H., Whole body irradiation; radiobiology or medicine? The British Journal of Radiology 1953 26 305 234 241 2-s2.0-0013071190
146. Dinarello C. A., Historical insights into cytokines. European Journal of Immunology 2007 37 1 S34 S45 2-s2.0-36248974200 10.1002/eji.200737772 (Pubitemid 350131266)
147. Cavaillon J.-M., Munoz C., Fitting C., Misset B., Carlet J., Circulating cytokines: the tip of the iceberg? Circulatory Shock 1992 38 2 145 152 2-s2.0-0026648849
148. Bower J. E., Ganz P. A., May L. T., Hu W., Belin T. R., Sepah S., Cole S., Aziz N., Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clinical Cancer Research 2009 15 17 5534 5540 2-s2.0-69949108874 10.1158/1078-0432.CCR-08-2584
149. Bower J. E., Ganz P. A., Irwin M. R., Arevalo J. M. G., Cole S. W., Fatigue and gene expression in human leukocytes: increased NF- B and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain, Behavior, and Immunity 2011 25 1 147 150 2-s2.0-78649323833 10.1016/j.bbi.2010.09.010
150. Min C.-K., Lee W. Y., Min D.-J., Lee D.-G., Kim Y.-J., Park Y. H., Kim H. J., Lee S., Kim D. W., Lee J. W., Min W. S., Kim C. C., The kinetics of circulating cytokines including IL-6, TNF- α IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation 2001 28 10 935 940 2-s2.0-0035203032 10.1038/sj.bmt.1703258 (Pubitemid 33130235)
151. Wratten C., Kilmurray J., Nash S., Seldon M., Hamilton C. S., O'Brien P. C., Denham J. W., Fatigue during breast radiotherapy and its relationship to biological factors. International Journal of Radiation Oncology, Biology, Physics 2004 59 1 160 167 2-s2.0-14644405515 10.1016/j.ijrobp.2003.10.008 (Pubitemid 38501520)
152. Landmark-Høyvik H., Reinertsen K. V., Loge J. H., Fosså S. D., Børresen-Dale A. L., Dumeaux V., Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics Journal 2009 9 5 333 340 2-s2.0-70349694295 10.1038/tpj.2009.27
153. Rishi A., Ghoshal S., Acute multiple arterial thrombosis after cisplatin in base of tongue carcinoma: case report. Head & Neck 2013 35 E269 E271
154. Haddad R., Sonis S., Posner M., Wirth L., Costello R., Braschayko P., Allen A., Mahadevan A., Flynn J., Burke E., Li Y., Tishler R. B., Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/ paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Cancer 2009 115 19 4514 4523 2-s2.0-70349271340 10.1002/cncr.24525
155. Blijlevens N. M. A., Donnelly J. P., DePauw B. E., Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplantation 2005 36 8 703 707 2-s2.0-27244458819 10.1038/sj.bmt.1705118 (Pubitemid 41518713)
156. Blijlevens N. M. A., Logan R. M., Netea M. G., The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis. The Journal of Antimicrobial Chemotherapy 2009 63 i36 i40 2-s2.0-66649104001 10.1093/jac/dkp081
157. Donnelly J. P., Muus P., Horrevorts A. M., Sauerwein R. W., DePauw B. E., Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients. Scandinavian Journal of Infectious Diseases 1993 25 1 43 50 2-s2.0-0027351810
158. Takatsuka H., Takemoto Y., Yamada S., Wada H., Tamura S., Fujimori Y., Okamoto T., Suehiro A., Kanamaru A., Kakishita E., Complications after bone marrow transplatation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplantation 2000 26 4 419 426 2-s2.0-0033841111 (Pubitemid 30649558)
159. Haisfield-Wolfe M. E., McGuire D. B., Soeken K., Geiger-Brown J., de Forge B., Suntharalingam M., Prevalence and correlates of symptoms and uncertainty in illness among head and neck cancer patients receiving definitive radiation with or without chemotherapy. Supportive Care in Cancer 2011 20 1885 1893 2-s2.0-80053358184 10.1007/s00520-011-1291-9
160. Ye Y., Carlsson G., Agholme M. B., Pretherapeutic plasma pro- and anti-inflammatory mediators are related to high risk of oral mucositis in pediatric patients with acute leukemia: a prospective cohort study. PLoS ONE 2013 8 5 10.1371/journal.pone.0064918 e64918
161. Pongratz G., Straub R. H., Role of peripheral nerve fibres in acute and chronic inflammation in arthritis. Nature Reviews Rheumatology 2013 9 117 126
162. Straub R. H., Cutolo M., Buttgereit F., Pongratz G., Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. Journal of Internal Medicine 2010 267 6 543 560 2-s2.0-77951935429 10.1111/j.1365-2796. 2010.02218.x
163. Pavlov V. A., Tracey K. J., Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochemical Society Transactions 2006 34 6 1037 1040 2-s2.0-33947239151 10.1042/BST0341037 (Pubitemid 46768984)
164. Ulloa L., The vagus nerve and the nicotinic anti-inflammatory pathway. Nature Reviews Drug Discovery 2005 4 8 673 684 2-s2.0-23844517664 10.1038/nrd1797 (Pubitemid 41149761)
165. Goldstein R. S., Bruchfeld A., Yang L., Qureshi A. R., Gallowitsch-Puerta M., Patel N. B., Huston B. J., Chavan S., Rosas-Ballina M., Gregersen P. K., Czura C. J., Sloan R. P., Sama A. E., Tracey K. J., Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Molecular Medicine 2007 13 3-4 210 215 2-s2.0-34250620898 10.2119/2006-00108.Goldstein (Pubitemid 46944965)
166. Wang H., Yu M., Ochani M., Amelia C. A., Tanovic M., Susarla S., Li J. H., Wang H., Yang N., Ulloa L., Al-Abed Y., Czura C. J., Tracey K. J., Nicotinic acetylcholine receptor α 7 subunit is an essential regulator of inflammation. Nature 2003 421 6921 384 388 2-s2.0-0037461768 10.1038/nature01339 (Pubitemid 36157937)
167. Borovikova L. V., Ivanova S., Zhang M., Yang H., Botchkina G. I., Watkins L. R., Wang H., Abumrad N., Eaton J. W., Tracey K. J., Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000 405 6785 458 462 2-s2.0-0034713266 10.1038/35013070 (Pubitemid 30367422)
168. Saeed R. W., Varma S., Peng-Nemeroff T., Sherry B., Balakhaneh D., Huston J., Tracey K. J., Al-Abed Y., Metz C. N., Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. Journal of Experimental Medicine 2005 201 7 1113 1123 2-s2.0-17144370981 10.1084/jem.20040463 (Pubitemid 40524679)
169. Brown D. J. F., McMillan D. C., Milroy R., The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 2005 103 2 377 382 2-s2.0-12344317715 10.1002/cncr.20777 (Pubitemid 40129298)
170. Bone R. C., Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Critical Care Medicine 1996 24 1 163 172 2-s2.0-0030011909
171. Evans W. J., Lambert C. P., Physiological basis of fatigue. American Journal of Physical Medicine and Rehabilitation 2007 86 1 S29 S46 2-s2.0-33847671332 10.1097/PHM.0b013e31802ba53c (Pubitemid 46352653)
172. Stone P. C., Minton O., Cancer-related fatigue. European Journal of Cancer 2008 44 8 1097 1104 2-s2.0-43449083180 10.1016/j.ejca.2008.02.037
173. Prue G., Rankin J., Allen J., Gracey J., Cramp F., Cancer-related fatigue: a critical appraisal. European Journal of Cancer 2006 42 7 846 863 2-s2.0-33646165014 10.1016/j.ejca.2005.11.026
174. Jereczek-Fossa B. A., Marsiglia H. R., Orecchia R., Radiotherapy-related fatigue. Critical Reviews in Oncology/Hematology 2002 41 3 317 325 2-s2.0-0036514098 10.1016/S1040-8428(01)00143-3 (Pubitemid 34203667)
175. Sawada N. O., de Paula J. M., Sonobe H. M., Zago M. M. F., Guerrero G. P., Nicolussi A. C., Depression, fatigue, and health-related quality of life in head and neck cancer patients: a prospective pilot study. Supportive Care in Cancer 2012 20 2705 2711 2-s2.0-84856389243 10.1007/s00520-012-1390-2
176. Smets E. M. A., Visser M. R. M., Willems-Groot A. F. M. N., Garssen B., Schuster-Uitterhoeve A. L. J., de Haes J. C. J. M., Fatigue and radiotherapy: (B) experience in patients 9 months following treatment. British Journal of Cancer 1998 78 7 907 912 2-s2.0-0031659783 (Pubitemid 28430020)
177. Visser M. R. M., Smets E. M. A., Fatigue, depression and quality of life in cancer patients: how are they related? Supportive Care in Cancer 1998 6 2 101 108 2-s2.0-0031911811 10.1007/s005200050142 (Pubitemid 28110532)
178. Morrow G. R., Hickok J. T., Roscoe J. A., Raubertas R. F., Andrews P. L. R., Flynn P. J., Hynes H. E., Banerjee T. K., Kirshner J. J., King D. K., Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Journal of Clinical Oncology 2003 21 24 4635 4641 2-s2.0-1542543332 10.1200/JCO.2003.04.070 (Pubitemid 46594038)
179. Roscoe J. A., Morrow G. R., Hickok J. T., Mustian K. M., Griggs J. J., Matteson S. E., Bushunow P., Qazi R., Smith B., Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Research and Treatment 2005 89 3 243 249 2-s2.0-18444389970 10.1007/s10549-004-2175-1 (Pubitemid 43293071)
180. Collado-Hidalgo A., Bower J. E., Ganz P. A., Cole S. W., Irwin M. R., Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clinical Cancer Research 2006 12 9 2759 2766 2-s2.0-33646733403 10.1158/1078-0432.CCR-05-2398
181. Saligan L. N., Kim H. S., A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain, Behavior, and Immunity 2012 26 830 848
182. Fox K. M., Brooks J. M., Gandra S. R., Markus R., Chiou C.-F., Estimation of cachexia among cancer patients based on four definitions. Journal of Oncology 2009 2009 7 2-s2.0-68349106982 10.1155/2009/693458 693458
183. Skipworth R. J. E., Stewart G. D., Dejong C. H. C., Preston T., Fearon K. C. H., Pathophysiology of cancer cachexia: much more than host-tumour interaction? Clinical Nutrition 2007 26 6 667 676 2-s2.0-34447541405 10.1016/j.clnu.2007.03.011 (Pubitemid 350107710)
184. Richey L. M., George J. R., Couch M. E., Kanapkey B. K., Yin X., Cannon T., Stewart P. W., Weissler M. C., Shores C. G., Defining cancer cachexia in head and neck squamous cell carcinoma. Clinical Cancer Research 2007 13 22 6561 6567 2-s2.0-36749087038 10.1158/1078-0432.CCR-07-0116 (Pubitemid 350206789)
185. Silver H. J., Dietrich M. S., Murphy B. A., Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head & Neck 2007 29 10 893 900 2-s2.0-38449088119 10.1002/hed.20607
186. Jatoi A., Ritter H. L., Dueck A., Nguyen P. L., Nikcevich D. A., Luyun R. F., Mattar B. I., Loprinzi C. L., A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer 2010 68 2 234 239 2-s2.0-77950459905 10.1016/j.lungcan.2009.06.020
187. Maltoni M., Fabbri L., Nanni O., Scarpi E., Pezzi L., Flamini E., Riccobon A., Derni S., Pallotti G., Amadori D., Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients. Supportive Care in Cancer 1997 5 2 130 135 2-s2.0-12644298682 10.1007/s005200050054 (Pubitemid 27163454)
188. Langen R. C. J., Schols A. M. W. J., Kelders M. C. J. M., Wouters E. F. M., Janssen-Heininger Y. M. W., Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor- B. FASEB Journal 2001 15 7 1169 1180 2-s2.0-0035020963 10.1096/fj.00-0463 (Pubitemid 32436302)
189. Baracos V., Rodemann H. P., Dinarello C. A., Goldberg A. L., Stimulation of muscle protein degradation and prostaglandin E2 release by leukocyte pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. The New England Journal of Medicine 1983 308 10 553 558 2-s2.0-0020678196 (Pubitemid 13141999)
190. Plata-Salamán C. R., Sonti G., Borkoski J. P., Wilson C. D., Ffrench-Mullen J. M. H., Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiology and Behavior 1996 60 3 867 875 2-s2.0-0030249710 10.1016/S0031-9384(96)00148-5 (Pubitemid 26284290)
191. Chesnokova V., Kariagina A., Melmed S., Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation. American Journal of Physiology 2002 282 5 E1110 E1118 2-s2.0-0036084284 (Pubitemid 34654726)
192. Bendtzen K., Baek L., Berild D., Demonstration of circulating leukocytic pyrogen/interleukin-1 during fever. The New England Journal of Medicine 1984 310 9, article 596 2-s2.0-0021359987
193. Castell J. V., Gomez-Lechon M. J., David M., Andus T., Geiger T., Trullenque R., Fabra R., Heinrich P. C., Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Letters 1989 242 2 237 239 2-s2.0-0024581491 10.1016/0014-5793(89)80476-4 (Pubitemid 19020112)
194. Bayliss T. J., Smith J. T., Schuster M., Dragnev K. H., Rigas J. R., A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer. Expert Opinion on Biological Therapy 2011 11 12 1663 1668 2-s2.0-80555127351 10.1517/14712598.2011.627850
195. Kubrak C., Olson K., Jha N., Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: a prospective longitudinal view. Head & Neck 2013 35 5 695 703 10.1002/hed.23023
196. Russi E. G., Corvò R., Merlotti A., Alterio D., Franco P., Pergolizzi S., de Sanctis V., Redda M. G. R., Ricardi U., Paiar F., Bonomo P., Merlano M. C., Zurlo V., Chiesa F., Sanguineti G., Bernier J., Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treatment Reviews 2012 38 1033 1049 2-s2.0-84860109577 10.1016/j.ctrv.2012.04.002